{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "hmdb:HMDB06564",
      "entity_text" : "glucose",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0079" ],
      "Cellular_component" : [ "uniprot:SL-0039" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "XREF_BIBR Oppositely to imatinib and dasatinib, case reports and clinical trials indicate that nilotinib increases blood glucose level and promotes diabetes mellitus.",
  "reading_complete" : "2020-08-02T14:12:08Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T14:10:16Z",
  "trigger" : "level",
  "evidence" : [ "glucose level" ],
  "pmc_id" : "6524858",
  "score" : 0
}